ONE FORMULATION
Reta-B1, Rethiamine and RetaBone: one formulation
Rethiamine™, Reta-B1™ and RetaBone™ are complementary identities for one proprietary Panacea Bio Chem research formulation: 5 mg retatrutide and 20 mg thiamine—vitamin B1—presented as a dual-layer Peptourbillon™ inside the lyophilised chamber of Lyoprester SS™, with a separate 0.5 mL P-EARLs™ reconstitution chamber.
Three names, three research perspectives — not three formulas:
- Rethiamine™ — the product and formulation identity. The definitive presentation of the formulation, the platform and the developer lives at rethiamine.com — the Rethiamine retatrutide and thiamine formulation ↗.
- Reta-B1™ — the thiamine and technical evidence identity. This site: the depletion question, the deficiency mechanisms, the formulation-compatibility work and the analytical programme.
- RetaBone™ — the body-composition and metabolic-resilience identity, at retabone.com — RetaBone body-composition research ↗.
This page is intentionally a signpost. To avoid duplicating product information across domains, it canonicalises to rethiamine.com, which carries the definitive formulation record.